Inerleukin-33 in inflammation and wound repair : an experimental study with special reference to endothelial cells and myofibroblats
Metadata
Vis metadataFinnes i følgende samling
- Institutt for klinisk medisin [10814]
Sammendrag
Sammendrag ikke registrert.Artikkelliste
Paper I: Küchler AM, Pollheimer J, Balogh J, Sponheim J, Manley L, Sørensen DR, De Angelis PM, Scott H, Haraldsen G. Nuclear interleukin-33 is generally expressed in resting endothelium but rapidly lost upon angiogenic or proinflammatory activation. Am J Pathol 2008, 173:1229-1242. The paper is removed from the thesis in DUO due to publisher restrictions. The published version is available at: https://doi.org/10.2353/ajpath.2008.080014 |
Paper II: Sponheim J, Pollheimer J, Olsen T, Balogh J, Hammarstrøm C, Loos T, Kasprzycka M, Sørensen DR, Nilsen HR, Küchler AM, Vatn MH, Haraldsen G. Inflammatory bowel disease-associated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts Am J Pathol 2010, 177:2804-2815. The paper is removed from the thesis in DUO due to publisher restrictions. The published version is available at: https://doi.org/10.2353/ajpath.2010.100378 |
Paper III: Pollheimer J, Balogh J, Sponheim J, Brox MJ, Loos T, Sundlisæter E, Vatn MH, Küchler AM, Haraldsen G. Interleukin-33 preferentially targets non-quiescent endothelial cells. Manuscript, to be published. The paper is removed from the thesis in DUO due to publisher restrictions. |
Paper IV: Sponheim J, Loos T, Rankin AL, Sundnes O, Røed-Nilsen H, Manley L, Scott H, Pflanz S, Haraldsen G. Interleukin-33 mediates neutrophil recruitment in immunity against Staphylococcus aureus. Manuscript, to be published. The paper is removed from the thesis in DUO due to publisher restrictions. |